Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin +/- Loperamide for Travelers' Diarrhea
NCT00292344Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifaximin in traveler's diarrhea (TD), sponsored by UTHealth Houston. Started Jun 2004; status: completed.
02
Drugs
rifaximin
03
Conditions
traveler's diarrhea (TD)
Beyond the preview
Go deeper on NCT00292344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00292344.